Should I buy Woolworths shares at $37?

Are Woolworths shares worth putting in the shopping basket?

| More on:
Woman thinking in a supermarket.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Woolworths shares have performed strongly in 2023 to date, compared to the ASX
  • The company achieved sales and earnings growth in the first half of FY23
  • However, one expert thinks the supermarket business is fully valued

The Woolworths Group Ltd (ASX: WOW) share price has been a good performer in the 2023 calendar year to date. It's up by almost 10%. That compares to just a 1% rise for the S&P/ASX 200 Index (ASX: XJO)

I don't think Woolworths shares are going to keep outperforming the S&P 200 by 9% per month this year. But the supermarket business could still represent a good opportunity at this level.

With that in mind, let's have a look at one expert's view on the company.

The Woolworths share price is 'fully valued'

Writing on The Bull, Arthur Garipoli from Seneca Financial Solutions pointed out that the recent FY23 half-year result was "marginally ahead of analyst forecasts".

He noted that group sales were $33.17 billion, before significant items – this represented an increase of 4% on the prior corresponding period. Earnings before interest and tax (EBIT) grew by 18.4% to $1.64 billion. Garipoli said that food sales were up and the performance of the Big W store performance "improved".

The supermarket business also pointed out that underlying earnings per share (EPS) grew by 11.7% while the dividend per share went up by 17.9% to 46 cents per share.

While food sales only increased by 2.5%, the food EBIT jumped 18.2%. This was boosted by a 48 basis point (0.48%) increase in the gross profit margin to 30.7% and a 30 basis point decline (0.3%) in the cost of doing business (CODB).

In other words, Woolworths has been able to achieve higher margins on the products it's selling, despite inflation impacts, and reduce its costs thanks to lower COVID costs.

After analysing these numbers, Garipoli said:

In our view, the company is fully valued at this point.

Outlook

Sometimes, outlook comments can have a sizeable impact on the Woolworths share price.

The Woolworths CEO Brad Banducci said that the business had a strong start to the FY23 second half.

Operating conditions have "continued to stabilise and sales growth has been robust", he said.

In Australian food, the company reported Woolworths' sales for the first seven weeks of the second half had increased by 6.5%.

Cost growth in the FY23 second half will "also benefit from the non-recurrence of COVID costs". It's also making "good progress on regaining momentum" with its productivity agenda. However, cost inflation in areas like "wages, energy, and supply chain" remains "material and well above recent history".

Woolworths share price snapshot

At the current valuation, the supermarket business has a market capitalisation of $45 billion according to the ASX.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

1 ASX dividend stock down 17% I'd buy right now

I’d happily do some pre-Christmas portfolio shopping with this ASX dividend stock.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade

I’m backing these ASX shares as long-term buys.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Opinions

2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

I'd buy this ASX dividend stock in any market

I’m planning to buy plenty more of this ASX stock in the coming months…

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

3 Aussie passive income stocks delivering decades upon decades of dividends

Income-focused investors could benefit from these stocks.

Read more »